-
1
المؤلفون: F. Estevinho, A. Figueiredo, E. Teixeira, J. Oliveira, A. Pego, A. Barroso, A. Faria, A. Fernandes, A. Chaves, A. Araújo, A. Meleiro, B. Parente, C. Matos, D. Canário, E. Camacho, F. Barata, G. Câmara, H. Queiroga, J. Lopes, J. Mellidez, L. Barradas, L. Ferreira, M. Felizardo, M. Figueiredo, M. Soares, M. Lopes, N. Gil, P. Fidalgo, R. Gomes, R. Vitorino, S. Valente, S. Silva, T. Cardoso, U. Brito, T. Almodovar
المصدر: Journal of Thoracic Oncology. 17:S250
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2baee916691ae60f16910051ac9ef93f
https://doi.org/10.1016/j .jtho.2022.07.423 -
2دورية أكاديمية
المؤلفون: Kubicka S; Cancer Center Reutlingen, Reutlingen, Germany. kubicka_s@klin-rt.de, Greil R, André T, Bennouna J, Sastre J, Van Cutsem E, von Moos R, Osterlund P, Reyes-Rivera I, Müller T, Makrutzki M, Arnold D
مؤلفون مشاركون: ML18147 study investigators including AIO, GERCOR, FFCD, UNICANCER GI, TTD, BGDO, GEMCAD, and AGMT groups
المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2013 Sep; Vol. 24 (9), pp. 2342-9. Date of Electronic Publication: 2013 Jul 12.
نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*therapeutic use , Colorectal Neoplasms/*drug therapy , Colorectal Neoplasms/*mortality , Proto-Oncogene Proteins/*metabolism , ras Proteins/*metabolism, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bevacizumab ; Biomarkers, Tumor/metabolism ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis/drug therapy ; Prospective Studies ; Proto-Oncogene Proteins p21(ras) ; Survival ; Treatment Outcome ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Young Adult